Page 1 of 1
Loading...
Page 1 of 1
The global neurorehabilitation market size was valued at $ 1,097.69 million in 2020 and is projected to reach $ 2,451.25 million by 2030 registering a CAGR of 8.3% from 2021 to 2030. ...
The central nervous disorders therapeutics market generated $1,17,556.10 million in 2020, and is projected to reach $2,32,294.20 million by 2030, growing at a CAGR of 7.3% from 2021 to 2030. Central nervous ...
The global monoclonal antibodies market size was valued at $146,642 million in 2020, and is projected to reach $390,582 million by 2030, registering a CAGR of 10.2% from 2021 to 2030.
The global autoinjectors market was valued at $ 1,509.0 million in 2019, and is expected to reach $ 5,732.6 million by 2027, with a CAGR of 18.1% during the forecast period.
The global stem cell umbilical cord blood market was valued at $3,110.8 million in 2019, and is projected to reach $10,135.20 million by 2027, registering a CAGR of 16.9% from 2020 to 2027.
Electronic drug delivery systems (EDDS) represents a trend in the advancement and development of drug delivery systems, that are interactive, portable, wirelessly connected and allow patient-administered therapy dropping overall healthcare cost. Insulin ...
Neurodegenerative disease or neurodegeneration refers to the progressive damage of nerve cells. Neurodegenerative diseases can lead to the loss of skills such as decision-making, and ultimately lead to loss of memory. Neurodegeneration ...
Page 1 of 1
There might be something that we haven’t covered in the scope and if it is as per your specific areas of interest, we can anytime customise and incorporate your requirements in the framework of the study and provide you with a customised report based on your exact needs.